TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Bloch Dissatisfied With PDQ, Offers $1 Million To fund “Tailored” Treatment Data To Physicians November 13, 1987
TCL Archive New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial September 24, 2010